Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid potential M&A concerns. The firm has recovered millions for shareholders in past cases.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), scrutinizing whether the infusion therapy company's shareholders are being adequately represented in any potential merger or acquisition transaction, according to a Monday announcement.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, is spearheading the probe. The firm describes itself as a specialist in mergers-and-acquisitions litigation and was recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report, a benchmark ranking in the securities litigation industry.
Read more Law Firm Probes Option Care Health Over Shareholder Rights →
The firm has a track record of recovering millions of dollars on behalf of shareholders in similar corporate transaction disputes. Investigations of this nature typically focus on whether a company's board of directors fulfilled its fiduciary duties to shareholders during deal negotiations, including whether the offered price fairly reflects the company's value.
Option Care Health, headquartered in Bannockburn, Illinois, is one of the largest providers of home and alternate-site infusion services in the United States. No details of a specific transaction or alleged wrongdoing were disclosed in the announcement, which is consistent with early-stage investigative proceedings commonly filed by plaintiff-side securities firms.
Shareholders of OPCH who have concerns about their legal rights or who wish to obtain additional information about the investigation are encouraged to contact Monteverde & Associates directly. Continue reading at All Financial Services & Investing.
